Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity
- PMID: 15322024
- PMCID: PMC517423
- DOI: 10.1128/IAI.72.9.5283-5291.2004
Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity
Abstract
Many studies have demonstrated that monocyte-derived macrophages display critical activities in immunity to parasites. The ability of these cells to process and present antigens, produce cytokines, and provide costimulatory signals demonstrates their pivotal role in initiating immune responses. Although potential modulatory function has been attributed to monocytes from patients with Chagas' disease, a systematic phenotypic and functional analysis of these cells has not been performed. In this work, we analyzed the ex vivo expression of important surface molecules (CD11b and HLA-DR) and immunoregulatory cytokines (interleukin-10 [IL-10], IL-12 and tumor necrosis factor alpha [TNF-alpha]) in CD14(+) and CD14(-) monocytes from Chagas' disease patients with polar clinical forms of the disease: indeterminate or severe cardiac. We also evaluated the influence of in vitro infection with T. cruzi in the expression of such molecules. We observed that monocytes from indeterminate-disease patients display lower levels of HLA-DR than those from noninfected individuals both ex vivo and after in vitro infection with T. cruzi. Although ex vivo expression of CD11b was similar among the groups, in vitro infection led to decreased expression of this molecule by monocytes from Chagas' disease patients but not from noninfected individuals. Analysis of the expression of immunoregulatory cytokines showed that while monocytes from indeterminate-disease patients are committed to IL-10 expression, a higher percentage of monocytes from cardiac-disease patients express TNF-alpha after exposure to live parasites. These results suggest that monocytes from indeterminate-disease patients display modulatory characteristics related to low HLA-DR and high IL-10 expression whereas monocytes from cardiac-disease, patients may be committed to induction of inflammatory responses related to high TNF-alpha expression.
Figures



Similar articles
-
Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.Infect Immun. 2007 Apr;75(4):1886-94. doi: 10.1128/IAI.01931-06. Epub 2007 Feb 5. Infect Immun. 2007. PMID: 17283096 Free PMC article.
-
Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.Hum Immunol. 2014 Jan;75(1):20-8. doi: 10.1016/j.humimm.2013.09.009. Epub 2013 Sep 24. Hum Immunol. 2014. PMID: 24071371
-
Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease.Immunobiology. 2012 Oct;217(10):1005-16. doi: 10.1016/j.imbio.2012.01.014. Epub 2012 Jan 20. Immunobiology. 2012. PMID: 22387073
-
[Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].Rev Argent Microbiol. 1996 Apr-Jun;28(2):99-109. Rev Argent Microbiol. 1996. PMID: 8768488 Review. Spanish.
-
Immunoregulatory mechanisms and Chagas' disease.Mem Inst Oswaldo Cruz. 1992;87 Suppl 5:101-3. doi: 10.1590/s0074-02761992000900015. Mem Inst Oswaldo Cruz. 1992. PMID: 1342703 Review.
Cited by
-
Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi.Vaccine. 2012 Nov 26;30(50):7179-86. doi: 10.1016/j.vaccine.2012.10.018. Epub 2012 Oct 15. Vaccine. 2012. PMID: 23079191 Free PMC article.
-
Lipid bodies: inflammatory organelles implicated in host-Trypanosoma cruzi interplay during innate immune responses.Mediators Inflamm. 2012;2012:478601. doi: 10.1155/2012/478601. Epub 2012 Apr 30. Mediators Inflamm. 2012. PMID: 22619483 Free PMC article.
-
Co-infection with distinct Trypanosoma cruzi strains induces an activated immune response in human monocytes.Parasite Immunol. 2019 Nov;41(11):e12668. doi: 10.1111/pim.12668. Epub 2019 Sep 30. Parasite Immunol. 2019. PMID: 31494949 Free PMC article.
-
Polymorphic sites at the immunoregulatory CTLA-4 gene are associated with chronic chagas disease and its clinical manifestations.PLoS One. 2013 Oct 24;8(10):e78367. doi: 10.1371/journal.pone.0078367. eCollection 2013. PLoS One. 2013. PMID: 24205212 Free PMC article.
-
Identification of Anti-Trypanosoma cruzi Lead Compounds with Putative Immunomodulatory Activity.Antimicrob Agents Chemother. 2018 Mar 27;62(4):e01834-17. doi: 10.1128/AAC.01834-17. Print 2018 Apr. Antimicrob Agents Chemother. 2018. PMID: 29437629 Free PMC article.
References
-
- Almeida, I. C., and R. T. Gazzinelli. 2001. Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. J. Leukoc. Biol. 70:467-477. - PubMed
-
- Bottrel, R. L., W. O. Dutra, F. A. Martins, B. Gontijo, E. Carvalho, M. Barral- Neto, A. Barral, R. P. Almeida, W. Mayrink, R. Locksley, and K. J. Gollob. 2001. Flow cytometric determination of cellular sources and frequencies of key cytokine- producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect. Immun. 69:3232-3239. - PMC - PubMed
-
- Brener, Z., and R. T. Gazzinelli. 1997. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol. 114:103-110. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials